Innovative research from Mount Sinai has also identified new pathways for research. Researchers at the Icahn School of Medicine at Mount Sinai have achieved a major breakthrough in Alzheimer's disease research. Their study identifies a promising method that could potentially slow or even stop the p
This study focuses on the manipulation of the plexin-B1 protein to enhance the brain’s ability to clear amyloid plaques in Alzheimer’s disease, opening avenues for future therapeutic strategies to potentially halt the progression of the disease
I'm surprised. As I understand it, the Alzheimer's field is starting to recognize that the plaques are likely a result of, rather than a cause of, the disease. And that the cause may be more related to a, potentially microglia related, inflammatory problem in the CNS
Thanks, that was a good read. It is terrible that some researchers end up committing such scientific fraud. Although I am inclined to blame the involved researchers themselves, ultimately, I believe that inflexible (and insufficient) funding is the real culprit